
Product News
Pistoia Alliance Enables Instant, Secure Transfer of Analytical Methods and Results Data Ahead of FDA Guidance
Successful proof of concept at GSK employs data transfer via cloud to facilitate secure and efficient collaboration across companies, labs and time zones.

Product News
Launch of High-Quality Enzymes Suitable for Pre-Clinical and Process Development in mRNA Vaccine
Takara Bio Europe announced the launch of new High Quality grade mRNA production enzymes "T7 RNA polymerase, HQ" and "Pyrophosphatase (inorganic), HQ" suitable for pre-clinical and process development in mRNA vaccine and therapeutic manufacturing.

Product News
Kuano Raises £1.8M in Seed Funding to Accelerate Quantum Drug Discovery
Kuano, announced the close of its £1.8M seed funding round. The investment will facilitate further validation of Kuano’s quantum simulation platform for the design of more effective drug candidates targeting enzymes.

Product News
Novartis Kisqali® Reduced the Risk of Cancer Recurrence While Maintaining Quality of Life
Novartis presents new patient-reported outcomes (PRO) data from the Phase III NATALEE trial at the European Society for Medical Oncology (ESMO) Virtual Plenary.

Product News
CN Bio and LifeNet Health LifeSciences Partner To Supply Validated Primary Human Cells for Microphysiological Systems
A new partnership to provide customers with direct access to highly characterized hepatic cells to recreate advanced Liver-on-a-Chip assays. These will alleviate the need for stringent in-house quality control testing to maximize assay success.

Product News
Optibrium Acquires BioPharmics LLC, Expanding Its 3D Drug Design and Visualisation Offering
Optibrium, announced the acquisition of BioPharmics LLC, expanding its 3D drug design and modelling offering. Bringing decades of experience in computational chemistry and biology.

Product News
Lab-on-Chip Technology for Screening Live Tumor
ScreenIn3D reports on how their proprietary lab-on-a-chip technology is enabling cancer researchers to miniaturize their testing of biopsy tissue samples across a wide range of modalities and to test both single and combination drug therapies.

Product News
RemeGen's Telitacicept Shows Significant Promise in Phase II Trial for Primary Sjogren's Syndrome
RemeGen Co., Ltd. announced that their Phase II clinical study of telitacicept for the treatment of Primary Sjögren's Syndromein adults has been published.

Product News
EmendoBio Scientists Participate in National Neutropenia Network Patient Retreat
Scientists attend national patient retreat and share scientific updates on investigational EMD-101 for severe congenital neutropenia treatment.

Product News
Metrion Biosciences Announces Launch of Good Laboratory Practice (GLP) hERG Screening Service
Metrion Biosciences announced it has received notification from the MHRA that the Company is now a member of the UK GLP Compliance Monitoring Programme.
Advertisement